stemcell
Flexible feeding, done right. Request a sample of new mTeSR™ Plus for hPSC maintenance
The Niche

The Niche

Knoepfler lab stem cell blog

  • Home
  • Contact
  • About Us
  • Trial search
  • Stem cells in your language
  • Treatments
  • Report bad clinic
  • Stem Cell Book
  • TED talk
  • Nature
  • Clinic List
  • Privacy Policy
  • RMAT List (25)
  • 2019 Meetings

Osiris (OSIR)

Ocata

Tale of 7 stem cell stock woes: how low can they go?

July 23, 2015 Paul Knoepfler 11

To get from point A of a stem cell discovery to point B of a patient actually receiving a treatment based on that discovery is a long and non-linear road. Stem cell biotech companies including publicly traded companies are an […]

No Picture

Mesoblast (MSB) buys Osiris (OSIR) stem cell unit

October 11, 2013 Paul Knoepfler 1

The Australian stem cell biotech Mesoblast (MSB) has reportedly reached a deal with the American stem cell biotech Osiris (OSIR) to buy Osiris’ mesenchymal stem cell (MSC) unit. This is a big development in the MSC field. Osiris and Mesoblast are […]

Subscribe to this Blog

Join 22,868 other subscribers

  • RSS - Posts
  • RSS - Comments

Recent Comments

  • Inga Andersdotter on Brief update from Bob Lanza on Astellas stem cell program
  • teamrivermist on Stem cell clinic doc being sued by FDA now gets agency warning for unapproved breast device
  • rickjaffe on Stem cell clinic doc being sued by FDA now gets agency warning for unapproved breast device
  • Jeanne Loring on Stem cell clinic doc being sued by FDA now gets agency warning for unapproved breast device
  • Saditt Ramos on Contact Us

Blogroll

  • BioPolitical Times
  • California Stem Cell Report
  • CIRM Blog
  • EuroStemCell
  • msemporda
  • RetractionWatch
  • Signals Blog
  • STAT
  • Stem Cell Battles
  • Stem Cells Portal
  • The Node

Copyright © 2019 | Designwork by Tradesouthwest Top